Cargando…

GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin

BACKGROUND AND OBJECTIVE: Chemotherapy drugs, such as cisplatin (DDP), improve the survival of patients with lung cancer by inducing apoptosis in cancer cells, which quickly develop resistance to DDP through uncharacterized mechanisms. Glioma Pathogenesis-Related Protein 1 (GLIPR1) plays an importan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Xin, Liu, Jing, Zhang, Dan, Yang, Dawei, Min, Zhihui, Wen, Xiaoxing, Wang, Guifang, Li, Huayin, Song, Yuanlin, Bai, Chunxue, Li, Jing, Zhou, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542429/ https://www.ncbi.nlm.nih.gov/pubmed/28771580 http://dx.doi.org/10.1371/journal.pone.0182410

Ejemplares similares

Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance
por: Rampioni Vinciguerra, Gian Luca, et al.
Publicado: (2023)

GLIPR1 Protects Against Cigarette Smoke-Induced Airway Inflammation via PLAU/EGFR Signaling
por: Peng, Wenjun, et al.
Publicado: (2021)

Denatonium inhibits growth and induces apoptosis of airway epithelial cells through mitochondrial signaling pathways
por: Wen, Xiaoxing, et al.
Publicado: (2015)

EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations
por: Gao, Jing, et al.
Publicado: (2016)

PD‐0332991 combined with cisplatin inhibits nonsmall cell lung cancer and reversal of cisplatin resistance
por: Liu, Minghui, et al.
Publicado: (2021)

Inhibition of MAT2A-Related Methionine Metabolism Enhances The Efficacy of Cisplatin on Cisplatin-Resistant Cells in Lung Cancer
por: Zhao, Xiaoya, et al.
Publicado: (2022)

Dexamethasone Reduces Sensitivity to Cisplatin by Blunting p53-Dependent Cellular Senescence in Non-Small Cell Lung Cancer
por: Ge, Haiyan, et al.
Publicado: (2012)

Combined time-restricted feeding and cisplatin enhance the anti-tumor effects in cisplatin-resistant and -sensitive lung cancer cells
por: Li, Jianling, et al.
Publicado: (2022)

Thioridazine Enhances Cisplatin-Induced DNA Damage in Cisplatin-Resistant Human Lung Cancer Cells
por: Luo, Yuanyuan, et al.
Publicado: (2022)

The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells
por: Guo, Jiwei, et al.
Publicado: (2018)

lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
por: Li, Qing, et al.
Publicado: (2018)

Applications of Machine Learning to Predict Cisplatin Resistance in Lung Cancer
por: Gao, Yanan, et al.
Publicado: (2021)

Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival
por: Dai, Chun-Hua, et al.
Publicado: (2016)

Variable Expression of GLIPR1 Correlates with Invasive Potential in Melanoma Cells
por: Awasthi, Anshul, et al.
Publicado: (2013)

Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2020)

Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury
por: Li, Jing, et al.
Publicado: (2015)

Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc
por: Zuo, Yufang, et al.
Publicado: (2018)

Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC
por: Tang, Zuxiong, et al.
Publicado: (2021)

Knockdown of PLAT enhances the anticancer effect of gefitinib in non-small cell lung cancer
por: Yan, Mengnan, et al.
Publicado: (2020)

GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
por: Karanika, Styliani, et al.
Publicado: (2015)

Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
por: Wangpaichitr, Medhi, et al.
Publicado: (2017)

Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells.
por: Kondo, S., et al.
Publicado: (1995)

miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells
por: Lin, Chen, et al.
Publicado: (2018)

Cisplatin in 5% Ethanol Eradicates Cisplatin-Resistant Lung Tumor by Killing Lung Cancer Side Population (SP) Cells and Non-SP Cells
por: Niu, Qi, et al.
Publicado: (2013)

Cancer‐associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells
por: Wang, Limin, et al.
Publicado: (2019)

Modulation of cisplatin cytotoxicity by sulphasalazine.
por: Awasthi, S., et al.
Publicado: (1994)

GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice
por: Friend, Natasha, et al.
Publicado: (2020)

TRP14 promotes resistance to cisplatin by inducing autophagy in ovarian cancer
por: Tan, Wen-Xi, et al.
Publicado: (2019)

Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells
por: Huang, Wei, et al.
Publicado: (2016)

The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer
por: O'Byrne, Kenneth J., et al.
Publicado: (2011)

The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma
por: Liu, Jing, et al.
Publicado: (2015)

Active Efflux System for Cisplatin in Cisplatin‐resistant Human KB Cells
por: Fujii, Ryu‐ichi, et al.
Publicado: (1994)

Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway
por: Wu, Tao, et al.
Publicado: (2015)

3′,4′,5′,5,7-Pentamethoxyflavone Sensitizes Cisplatin-Resistant A549 Cells to Cisplatin by Inhibition of Nrf2 Pathway
por: Hou, Xiangyu, et al.
Publicado: (2015)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2019)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

Cisplatin, glutathione and the third wheel: a copper-(1,10-phenanthroline) complex modulates cisplatin–GSH interactions from antagonism to synergism in cancer cells resistant to cisplatin
por: Vascellari, Sarah, et al.
Publicado: (2019)

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance
por: Ma, Qingshan, et al.
Publicado: (2012)

Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
por: Shi, Zhen-duo, et al.
Publicado: (2022)

Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression
por: Zhang, Wendian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_blqr5ler9a4op3ekjg1mtq0oq0